Form 4 for BOLT Bolt Biotherapeutics, Inc.
Accepted 2023-12-13 00:00:00 ET · period of report 2023-12-12 · accession 0001209191-23-058458 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-13 | 2023-06-06+ | BOLT | Quinn William P. | CFO | P - Purchase | $0.9496 | +11.8K | 26.3K | +82% | +$11.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-12 | P | A | 7,500 | $0.95 | 36,272 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-06 | P | A | 2,500 | $0.78 | 28,772 | D | — | — | (F1) Shares acquired under the issuer's Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2023-06-06 | P | A | 1,829 | $1.18 | 26,272 | D | — | — | (F1) Shares acquired under the issuer's Employee Stock Purchase Plan. |